168 related articles for article (PubMed ID: 14632574)
1. Primary cervical adenocarcinoma with intestinal differentiation and colonic carcinoma metastatic to cervix: an investigation using Cdx-2 and a limited immunohistochemical panel.
Raspollini MR; Baroni G; Taddei A; Taddei GL
Arch Pathol Lab Med; 2003 Dec; 127(12):1586-90. PubMed ID: 14632574
[TBL] [Abstract][Full Text] [Related]
2. CDX-2, cytokeratin 7 and cytokeratin 20 immunohistochemical expression in the differential diagnosis of primary adenocarcinomas of the sinonasal tract.
Franchi A; Massi D; Palomba A; Biancalani M; Santucci M
Virchows Arch; 2004 Jul; 445(1):63-7. PubMed ID: 15175880
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemistry in the differential diagnosis between primary and secondary intestinal adenocarcinoma of the urinary bladder.
Raspollini MR; Nesi G; Baroni G; Girardi LR; Taddei GL
Appl Immunohistochem Mol Morphol; 2005 Dec; 13(4):358-62. PubMed ID: 16280666
[TBL] [Abstract][Full Text] [Related]
4. Intestinal-type cervical adenocarcinoma in situ and adenocarcinoma exhibit a partial enteric immunophenotype with consistent expression of CDX2.
McCluggage WG; Shah R; Connolly LE; McBride HA
Int J Gynecol Pathol; 2008 Jan; 27(1):92-100. PubMed ID: 18156982
[TBL] [Abstract][Full Text] [Related]
5. The value of Cdx2 immunostaining in differentiating primary ovarian carcinomas from colonic carcinomas metastatic to the ovaries.
Groisman GM; Meir A; Sabo E
Int J Gynecol Pathol; 2004 Jan; 23(1):52-7. PubMed ID: 14668551
[TBL] [Abstract][Full Text] [Related]
6. CDX-2 homeobox gene expression is a reliable marker of colorectal adenocarcinoma metastases to the lungs.
Barbareschi M; Murer B; Colby TV; Chilosi M; Macri E; Loda M; Doglioni C
Am J Surg Pathol; 2003 Feb; 27(2):141-9. PubMed ID: 12548159
[TBL] [Abstract][Full Text] [Related]
7. CDX-2 expression is a common event in primary intestinal-type endocervical adenocarcinoma.
Saad RS; Ismiil N; Dubé V; Nofech-Mozes S; Khalifa MA
Am J Clin Pathol; 2009 Oct; 132(4):531-8. PubMed ID: 19762530
[TBL] [Abstract][Full Text] [Related]
8. Expression pattern of CK7, CK20, CDX-2, and villin in intestinal-type sinonasal adenocarcinoma.
Kennedy MT; Jordan RC; Berean KW; Perez-Ordoñez B
J Clin Pathol; 2004 Sep; 57(9):932-7. PubMed ID: 15333652
[TBL] [Abstract][Full Text] [Related]
9. [Immunohistochemical profile of colorectal and ovarian carcinomas--examination with cytokeratin 7, cytokeratin 20, beta catenin and cDX 2].
Porjazova E; Zaprjanov Z; Batashki I; Markova D; Milchev N
Akush Ginekol (Sofiia); 2009; 48(2):7-12. PubMed ID: 20198769
[TBL] [Abstract][Full Text] [Related]
10. Value of a panel of antibodies to identify the primary origin of adenocarcinomas presenting as bladder carcinoma.
Torenbeek R; Lagendijk JH; Van Diest PJ; Bril H; van de Molengraft FJ; Meijer CJ
Histopathology; 1998 Jan; 32(1):20-7. PubMed ID: 9522212
[TBL] [Abstract][Full Text] [Related]
11. Tracing the origin of adenocarcinomas with unknown primary using immunohistochemistry: differential diagnosis between colonic and ovarian carcinomas as primary sites.
Lagendijk JH; Mullink H; Van Diest PJ; Meijer GA; Meijer CJ
Hum Pathol; 1998 May; 29(5):491-7. PubMed ID: 9596273
[TBL] [Abstract][Full Text] [Related]
12. [Expression of cytokeratin 7 and 20 in ovarian metastatic carcinomas].
Dai L; Song Q; Li L; Zhong D; Hui Y
Zhonghua Bing Li Xue Za Zhi; 2001 Apr; 30(2):114-7. PubMed ID: 11866966
[TBL] [Abstract][Full Text] [Related]
13. Colonic adenocarcinoma metastatic to the urinary tract versus primary tumors of the urinary tract with glandular differentiation: a report of 7 cases and investigation using a limited immunohistochemical panel.
Tamboli P; Mohsin SK; Hailemariam S; Amin MB
Arch Pathol Lab Med; 2002 Sep; 126(9):1057-63. PubMed ID: 12204054
[TBL] [Abstract][Full Text] [Related]
14. Pulmonary intestinal-type adenocarcinoma does not show enteric differentiation by immunohistochemical study.
Yousem SA
Mod Pathol; 2005 Jun; 18(6):816-21. PubMed ID: 15605076
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical differentiation between primary adenocarcinomas of the ovary and ovarian metastases of colonic and breast origin. Comparison between a statistical and an intuitive approach.
Lagendijk JH; Mullink H; van Diest PJ; Meijer GA; Meijer CJ
J Clin Pathol; 1999 Apr; 52(4):283-90. PubMed ID: 10474521
[TBL] [Abstract][Full Text] [Related]
16. Cytokeratins 7 and 20 and carcinoembryonic antigen in ovarian and colonic carcinoma.
Berezowski K; Stastny JF; Kornstein MJ
Mod Pathol; 1996 Apr; 9(4):426-9. PubMed ID: 8729984
[TBL] [Abstract][Full Text] [Related]
17. The usefulness of CDX-2 for differentiating primary and metastatic ovarian carcinoma: an immunohistochemical study using a tissue microarray.
Kim MJ
J Korean Med Sci; 2005 Aug; 20(4):643-8. PubMed ID: 16100458
[TBL] [Abstract][Full Text] [Related]
18. Cytokeratin 7-positive/cytokeratin 20-negative cecal adenocarcinoma metastatic to the uterine cervix: a case report.
Toyoshima M; Momono Y; Makino H; Kudo T; Oka N; Sakurada J; Suzuki H; Kodama H; Yoshinaga K
World J Surg Oncol; 2016 Jan; 14(1):22. PubMed ID: 26810414
[TBL] [Abstract][Full Text] [Related]
19. Among sinonasal tumors, CDX-2 immunoexpression is not restricted to intestinal-type adenocarcinomas.
Tilson MP; Gallia GL; Bishop JA
Head Neck Pathol; 2014 Mar; 8(1):59-65. PubMed ID: 23846317
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of Cdx2 in separating mucinous bronchioloalveolar adenocarcinoma of the lung from metastatic mucinous colorectal adenocarcinoma.
Saad RS; Cho P; Silverman JF; Liu Y
Am J Clin Pathol; 2004 Sep; 122(3):421-7. PubMed ID: 15362373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
